A clear trend, although not statistically significant, was also observed in gastric cancers (mainly because of immunotherapy administration in MSI-H and high TMB patients).
← all excerpts
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
1
—
—